EV/EBITDA
-0.65
+0.06+8.45%
4 min ago
Summary
- As of February 7, 2025, CTCX EV/EBITDA is -0.65, with a rise of +0.06 (+8.45%) during the most recent trading day.
- Over the past year, CTCX EV/EBITDA has increased by +4.60 (+87.62%).
- CTCX EV/EBITDA is now -103.13% below its all-time high of -0.32.
Performance
CTCX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CTCX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +8.4% | -8.5% | -8.0% |
| 1 m1 month | +25.3% | -25.3% | -24.2% |
| 3 m3 months | -6.6% | +6.8% | +6.4% |
| 6 m6 months | +52.9% | -71.0% | -71.2% |
| ytdytd | -12.1% | +11.8% | +11.1% |
| 1 y1 year | +87.6% | -92.3% | -91.0% |
| 5 y5 years | - | - | - |
CTCX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.6% | -1.25 | +48.0% | |
| 3 m | 3-month | -0.43 | -51.2% | -1.34 | +51.5% |
| 6 m | 6-month | -0.32 | -103.1% | -1.46 | +55.5% |
| 1 y | 1-year | -0.32 | -103.1% | -5.68 | +88.6% |
| 3 y | 3-year | -0.32 | -103.1% | -13.62 | +95.2% |
| 5 y | 5-year | -0.32 | -103.1% | -13.62 | +95.2% |
| alltime | all time | -0.32 | -103.1% | -13.62 | +95.2% |
Carmell Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.65(+12.1%) |
| Date | Value |
|---|---|
| 2024 | -0.58(-89.9%) |
| 2023 | -5.77 |
FAQ
- What is Carmell Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Carmell Therapeutics?
- What is CTCX EV/EBITDA year-to-date change?
- What is Carmell Therapeutics EV/EBITDA year-on-year change?
What is Carmell Therapeutics EV/EBITDA?
The current EV/EBITDA of CTCX is -0.65
What is the all time high EV/EBITDA for Carmell Therapeutics?
Carmell Therapeutics all-time high EV/EBITDA is -0.32
What is CTCX EV/EBITDA year-to-date change?
Carmell Therapeutics EV/EBITDA has changed by -0.07 (-12.07%) since the beginning of the year
What is Carmell Therapeutics EV/EBITDA year-on-year change?
Over the past year, CTCX EV/EBITDA has changed by +4.60 (+87.62%)